IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
August 5, 2020
Philadelphia, PA, August 5, 2019 – IntegriChain, a leading data and managed services company helping Life Sciences manufacturers deliver access to innovative therapies that significantly improve patient lives, today announced that the company’s subject matter experts will present at the upcoming CBI Accounting and Reporting Congress. The virtual conference runs August 10-13, with a Commercial Forecasting and Modeling Summit following on August 18.
IntegriChain speakers include:
Jeff Baab, Executive Director, Advisory Services, will present “High-Materiality Issues Impacting Gross-to-net Liabilities and Adjustments” on Wednesday, August 12 at 10:30 am ET.
Angelina Pigna, Director, Gross-to-Net Advisory Services, “Laying the GTN Groundwork within an Early Commercial Revenue Company: A Roadmap for Success,” on Thursday, August 13 at 1:15 pm ET.
Afaque Amanulla, Director, Advisory Services, chairs the Commercial Forecasting and Modeling Summit and will present on “Financial Planning and Forecasting Process Optimization for Commercial Success” on August 18 at 11 am ET.
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 230 manufacturers rely on IntegriChain’s ICyte Platform of analytics, applications, managed services and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India.For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | jennifer@sagestrat.com
Webinars & Resources
See List
Register Today
